<DOC>
	<DOCNO>NCT02065908</DOCNO>
	<brief_summary>In propose project investigator asses whether change expression select circulate microRNAs serum could comprise sensitive specific biomarker cardiotoxicity cancer patient treat anthracyclines base chemotherapy .</brief_summary>
	<brief_title>Circulating MicroRNA Biomarker Cardiotoxicity Breast Cancer</brief_title>
	<detailed_description>Blood take 1. anthracycline base chemotherapy administration 2. middle anthracycline treatment ( 3rd and/or 5th cycle drug infusion ) 3. anthracycline chemotherapy cessation 4 . 6 month chemotherapy cessation end point occur 5 . 12 month chemotherapy cessation end point occur Echocardiography perform 1. anthracycline base chemotherapy administration 2. anthracycline base chemotherapy cessation 3 . 6 month anthracycline base chemotherapy cessation 4 . 12 month anthracycline base chemotherapy cessation end point observe earlier The investigator perform high-throughput miRNA ( microRNA ) expression profile serum sample - call training set . Training set consist sera 30 patient reach end point . Training set sequence use next generation sequence . Training set use derive miRNA signature capable separate early cardiotoxicity patient healthy one . MiRNA signature validate use validation set .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>age 1870 stage IIII TNM ( Tumor Node Metastases ) second next cancer ( except basal cell skin cancer CIN ) previously treat chemotherapy previously treat radiotherapy acute myocardial infarction heart failure cardiomyopathy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>anthracyclines</keyword>
	<keyword>cardiotoxicity</keyword>
	<keyword>circulate microRNA</keyword>
	<keyword>biomarker</keyword>
	<keyword>serum</keyword>
	<keyword>anthracyclines base chemotherapy</keyword>
</DOC>